✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Vitrolife AB

Common Name
Vitrolife
Country
Sweden
Sector
Healthcare
Industry
Medical Devices
Employees
1,102
Ticker
VITR
Exchange
NASDAQ STOCKHOLM AB
Description
Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company d...

Vitrolife's GHG Emissions Data Preview

In 2025, Vitrolife completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Vitrolife has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Location-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Unspecified Calculation Method
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Limited Data Preview
You are viewing a limited preview of Vitrolife’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=VITR&reporting_period=2025"

Verified Sources Behind Vitrolife’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vitrolife’s data sources below and access millions more through our Disclosure Search.

a. Vitrolife's Annual Report 2025
b. Vitrolife's Annual Report 2022

Insights into Vitrolife's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Vitrolife amounted to 1,943 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Vitrolife decreased by 3.04%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Vitrolife's Scope 1 Emissions Over Time

202120222023202420250200400600800tCO2e-4%-4%+1%-18%
  • Total Scope 1
  • Year-over-Year Change

What are Vitrolife's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Vitrolife were 610 metric tons of CO₂ equivalent (tCO₂e).a

Has Vitrolife reduced its Scope 1 emissions over time?

Since 2021, Vitrolife's Scope 1 emissions have decreased by 23.03%, reflecting a declining long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2024), Vitrolife's Scope 1 emissions decreased by 17.79%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Vitrolife's Scope 2 emissions?

In 2025, Vitrolife reported Scope 2 greenhouse gas (GHG) emissions of 1,260 tCO₂e using the market-based method and 1,333 tCO₂e using the location-based method.a

Has Vitrolife reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Vitrolife's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Vitrolife's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Vitrolife use for Scope 2 reporting?

In 2025, Vitrolife reported its Scope 2 emissions using the market-based method and using the location-based method.a

Vitrolife's Scope 2 Emissions Over Time

2021202220232024202503507001.05 k1.4 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Vitrolife's Value Chain Emissions

In 2025, Vitrolife reported 18,849 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Vitrolife includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Vitrolife's Scope 3 Emissions Over Time

2021202220232024202505 k10 k15 k20 ktCO2e+1004%+20%-8%+4%
  • Total Scope 3
  • Year-over-Year Change

What are Vitrolife's Scope 3 emissions?

In 2025, Vitrolife reported total Scope 3 emissions of 18,849 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 90.83% of these emissions originated from upstream activities such as purchased goods and capital goods, while 9.17% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Vitrolife reduced its Scope 3 emissions over time?

Since 2021, Vitrolife's Scope 3 emissions have increased by 1,174.44%, reflecting a rising long-term trend in Scope 3 emissions over time.ab

Compared to the previous year (2024), Vitrolife's Scope 3 emissions remained relatively stable, indicating that Vitrolife's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Vitrolife disclose?

In 2025, Vitrolife reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Vitrolife's Scope 3 emissions?

In 2025, the largest contributors to Vitrolife's Scope 3 emissions were:a

  • Upstream Transportation and Distribution (Cat. 4): 6,643 tCO₂e (35.25%)
  • Purchased Goods and Services (Cat. 1): 3,950 tCO₂e (20.96%)
  • Business Travel (Cat. 6): 2,796 tCO₂e (14.83%)

Vitrolife's Scope 3 Emissions by Categories

UpstreamTransportation andDistribution(Cat. 4)(35.2%)Purchased Goods andServices (Cat. 1)(21.0%)Business Travel(Cat. 6)(14.8%)

Insights into Vitrolife’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Vitrolife reported Scope 1 greenhouse gas (GHG) emissions of 610 tCO₂e and total revenues of USD 374 millions. This translates into an emissions intensity of 1.63 tCO₂e per millions USD.a

Vitrolife's Scope 1 Emissions Intensity Compared to Peers

101002,00020,000200,000Scope 1 Emissions (tCO2e)502002,00010,00050,000Revenues (Millions of USD)EIStratecYear: 2024Scope 1: 814 tCO2eRevenue: $M 268Scope 1 Intensity: 3.04 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MSectraYear: 2024Scope 1: 148 tCO2eRevenue: $M 269Scope 1 Intensity: 0.55 tCO2e/$MLifeTech ScientificYear: 2023Scope 1: 1,528 tCO2eRevenue: $M 178Scope 1 Intensity: 8.57 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MIon Beam ApplicationsYear: 2025Scope 1: 1,354 tCO2eRevenue: $M 729Scope 1 Intensity: 1.86 tCO2e/$MElektaYear: 2025Scope 1: 5,007 tCO2eRevenue: $M 1,865Scope 1 Intensity: 2.69 tCO2e/$MBICO GroupYear: 2024Scope 1: 37 tCO2eRevenue: $M 157Scope 1 Intensity: 0.24 tCO2e/$MNolatoYear: 2024Scope 1: 1,587 tCO2eRevenue: $M 877Scope 1 Intensity: 1.81 tCO2e/$MAmbuYear: 2025Scope 1: 3,165 tCO2eRevenue: $M 948Scope 1 Intensity: 3.34 tCO2e/$MSysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MDraegerwerk AG & CoYear: 2025Scope 1: 30,584 tCO2eRevenue: $M 4,094Scope 1 Intensity: 7.47 tCO2e/$MSmith & NephewYear: 2024Scope 1: 12,794 tCO2eRevenue: $M 5,810Scope 1 Intensity: 2.20 tCO2e/$MKoninklijke PhilipsYear: 2024Scope 1: 17,783 tCO2eRevenue: $M 18,753Scope 1 Intensity: 0.95 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$MEEEmbla MedicalYear: 2024Scope 1: 2,290 tCO2eRevenue: $M 5,405Scope 1 Intensity: 0.42 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MGetinge publYear: 2025Scope 1: 11,650 tCO2eRevenue: $M 3,802Scope 1 Intensity: 3.06 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MClassysYear: 2023Scope 1: 237 tCO2eRevenue: $M 141Scope 1 Intensity: 1.68 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MGN Store NordYear: 2025Scope 1: 2,912 tCO2eRevenue: $M 2,642Scope 1 Intensity: 1.10 tCO2e/$MVitrolifeYear: 2025Scope 1: 610 tCO2eRevenue: $M 374Scope 1 Intensity: 1.63 tCO2e/$M

How does Vitrolife's GHG emissions intensity compare to its peers?

In 2025, Vitrolife reported a Scope 1 emissions intensity of 1.63 tCO₂e per millions USD. Compared to the peer group median of 2.13, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Vitrolife rank on GHG emissions intensity within its industry?

In 2025, Vitrolife ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Vitrolife is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Vitrolife's Total Carbon Footprint

In 2025, Vitrolife reported a total carbon footprint of 20,792 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.72% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Vitrolife's total carbon footprint was Scope 3 emissions, accounting for 90.66% of the company's total carbon footprint, followed by Scope 2 emissions at 6.41%.a

Want Full Access to Vitrolife's GHG Emissions Dataset?
Start 30-Day Free Trial